US$ 26.71
gip and glp 1 drugs Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Personalized GLP-1/GIP+B12 - Kin Meds
Description
The bioavailability amounts to 80%

Wharton S, Davies M, Dicker D, et al
Key Takeaways: GLP-1 medications are approved in India for managing type 2 diabetes and, in some cases, weight management

2023;381:e074068

Saxenda may be the new kid on the block for obesity management but its not a new medication
